Hepatic sinusoidal obstruction syndrome induced by non-transplant chemotherapy for non-hodgkin lymphoma

Miho Sakumura, Kazuto Tajiri*, Shigeharu Miwa, Kohei Nagata, Kengo Kawai, Takayoshi Miyazono, Kotaro Arita, Akinori Wada, Jun Murakami, Toshiro Sugiyama

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Hepatic sinusoidal obstruction syndrome (SOS), a serious complication that mainly occurs after hematopoietic-stem cell transplantation (HSCT), is caused by damage to the sinusoidal endothelial cells after the obstruction of the sinusoid. Recently, hepatic SOS was reported to occur after non-HSCT chemotherapies. This report describes a patient who experienced hepatic SOS after non-HSCT chemotherapy for non-Hodgkin lymphoma. A liver biopsy showed the slight dilatation of the hepatic sinusoid, which may be indicative of hepatic SOS. Hepatic SOS should be included in the differential diagnosis of patients with severe liver injury following the administration of chemotherapy regimens that are toxic to the vascular endothelial cells.

Original languageEnglish
Pages (from-to)395-400
Number of pages6
JournalInternal Medicine
Volume56
Issue number4
DOIs
StatePublished - 2017

Keywords

  • Chemotherapy
  • Cyclophosphamide
  • Drug-induced liver injury
  • Jaundice
  • Sinusoidal obstruction syndrome

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Hepatic sinusoidal obstruction syndrome induced by non-transplant chemotherapy for non-hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this